Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCD-131 in Healthy Volunteers
NCT02731469Phase 1Completed
- Sponsor
- BIOCAD
- Start
- Jun 2016
- Primary completion
- Mar 2017
- Modality
- Recombinant Proteins and Enzymes, PEGylated Peptides
01
Overview
Phase 1, open-label trial of pegylated darbepoetin beta in anemia, sponsored by BIOCAD. Started Jun 2016; status: completed.
02
Drugs
pegylated darbepoetin beta
03
Conditions
anemia
Beyond the preview
Go deeper on NCT02731469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02731469.